Search research articles
Contact Us
Filters
Showing results (721-730 of 826) with videos related to
Page
of 83
Sort By:
Leukemia
|
July 1, 2026
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia
Clarissa Garcia, Kaylyn U Lyons, Julian Grandvallet Contreras, et al.
Blood Cancer Journal
|
April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genes
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Transfusion
|
April 1, 2015
Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial
Deborah J Novak, Yu Bai, Rhonda K Cooke, et al.
Leukemia
|
March 22, 2017
Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide
S Kayser, J Krzykalla, M A Elliott, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2024
Small-molecule disruption of androgen receptor-dependent chromatin clusters
Sarah E Kohrt, Emily J Novak, Subhashish Tapadar, et al.
Science (New York, N.Y.)
|
November 18, 2017
Natural selection shaped the rise and fall of passenger pigeon genomic diversity
Gemma G R Murray, André E R Soares, Ben J Novak, et al.
British Journal of Haematology
|
October 3, 2012
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes
Susan L Slager, Nicola J Camp, Lucia Conde, et al.
Nature Communications
|
August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Blood Cancer Journal
|
August 8, 2025
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts
Patrizia Mondello, Brianna Negaard, Andrew L Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
Page
of 83
Search research articles
Search
Showing results (721-730 of 826) with videos related to
Sort By:
Page
of 83
Leukemia
|
July 1, 2026
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia
Clarissa Garcia, Kaylyn U Lyons, Julian Grandvallet Contreras, et al.
Blood Cancer Journal
|
April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genes
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Transfusion
|
April 1, 2015
Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial
Deborah J Novak, Yu Bai, Rhonda K Cooke, et al.
Leukemia
|
March 22, 2017
Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide
S Kayser, J Krzykalla, M A Elliott, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2024
Small-molecule disruption of androgen receptor-dependent chromatin clusters
Sarah E Kohrt, Emily J Novak, Subhashish Tapadar, et al.
Science (New York, N.Y.)
|
November 18, 2017
Natural selection shaped the rise and fall of passenger pigeon genomic diversity
Gemma G R Murray, André E R Soares, Ben J Novak, et al.
British Journal of Haematology
|
October 3, 2012
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes
Susan L Slager, Nicola J Camp, Lucia Conde, et al.
Nature Communications
|
August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Blood Cancer Journal
|
August 8, 2025
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts
Patrizia Mondello, Brianna Negaard, Andrew L Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
Page
of 83